Explore more publications!

Press Releases

Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
Eleva appoints Erich Rajkovic as new Chief Business Officer
Faex Health Announces Upcoming Launch of AI-Powered Gut Health Platform
Farmer and Forestry Worker Health & Well-Being at the Maine Agricultural Trades Show

Farmer and Forestry Worker Health & Well-Being at the Maine Agricultural Trades Show

Top Water Socks Supplier Industry Analysis: Water Sports Demand Growth and Supply Chain Trends
Global Leading Distribution Transformer Supplier Unveils Tech at Dubai MEE 2025
Farmer and Forestry Worker Health & Well-Being at the Maine Agricultural Trades Show

Farmer and Forestry Worker Health & Well-Being at the Maine Agricultural Trades Show

Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus  
Dr. Andrea Adams-Miller Warns That CDC-Reported Record Flu Activity Is Driving Stress and That Mental Health Support Is Critical Right Now
Ventis Medical Announces Distribution Partnership with Bound Tree Medical to Revolutionize EMS Respiratory Care
Medical Radiation Shielding Market Size Is Valued At USD 3.2 Bn By 2034 | CAGR of 7.20%
QuanBio Appoints Aubrey C. Galloway, MD, as Chief Medical Officer
Agilon Healthc, Inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Agilon Health, Inc. Class Action Lawsuit
C3 HealthcareRx and Wellbox Health Merge to Form a Comprehensive Value-Based Care Organization
Range Impact Announces Two Major Land Acquisitions in Kentucky and Sale of Abandoned Mine Land Services Business
ProMed Pharma Announces Agreement with Undisclosed Partner for Dedicated Manufacturing Suite at New Niagara Ln Facility
LENZ Therapeutics Reports Fourth Quarter 2025 Preliminary Unaudited Financial Results and Recent Corporate Updates
Onco360® Has Partnered with Rigel Pharmaceuticals to Add Three Therapies to Its Limited Distribution Portfolio

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions